Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
about
Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugsEarly increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imagingMultiscale tumor spatiokinetic model for intraperitoneal therapyTwo-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin.Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles.Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategiesImproving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.Method to Assess Interactivity of Drugs with Nonparallel Concentration-Effect Relationships.Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies.Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis.Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.
P2860
Q27687617-4620023C-3369-4918-8219-F34BCD66581FQ28568967-6590543C-29F7-4746-9F1B-8BD2ABAD6E71Q30606326-B6856034-A36F-422A-BFDD-A5446BD63D96Q33574144-C9D76ADF-B9DE-4CCE-B35D-285CE9C107FAQ34768920-A8EA58AB-793D-4055-91D6-5DBC52A43217Q35882024-D75D0BA5-5DFD-4A92-9F12-5ADA1AF7C399Q36092777-C1BA0589-626B-43F6-A4B3-7F28BFB1C18AQ36438435-9B873CA1-67D5-4DA9-A84D-32731845852DQ36840074-32B6CC6A-8928-43F2-96FD-3626EAA56939Q36848111-81CF4FD0-B6DD-4CAF-850D-BBE3C6504708Q36963585-A6C2E57C-155F-4FCF-A653-8EDF3EFBEF86Q38866872-16440B2F-067B-4FF0-AFA6-C6DC4CB6DAFFQ39129504-6AA6E609-2FEB-4347-B171-392BB5FAEE38Q39557339-D838B2FA-E97A-4F3F-8F08-CF33040F6331Q39986942-786254B8-B964-432E-9A74-3CA252AB2266Q41936079-B3C12F43-CA56-474B-9DEA-05DD188E4377Q41963914-398D9691-B427-49BB-AABB-BA99AD13B409Q47622996-85964F45-8B05-4732-87F8-D674BBD23905
P2860
Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Pharmacodynamics of immediate ...... intracellular drug retention.
@en
Pharmacodynamics of immediate ...... intracellular drug retention.
@nl
type
label
Pharmacodynamics of immediate ...... intracellular drug retention.
@en
Pharmacodynamics of immediate ...... intracellular drug retention.
@nl
prefLabel
Pharmacodynamics of immediate ...... intracellular drug retention.
@en
Pharmacodynamics of immediate ...... intracellular drug retention.
@nl
P2093
P1433
P1476
Pharmacodynamics of immediate ...... intracellular drug retention.
@en
P2093
Johnson AL
Johnston J
Millenbaugh NJ
P304
P407
P577
1998-05-01T00:00:00Z